Citigroup Inc Agile Therapeutics Inc Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.21 - $0.31 $21 - $31	-100 Reduced 1.09%	9,085 $1,000
Q4 2022 Feb 09, 2023	BUY	$0.18 - $15.25 $18 - $1,525	100 Added 1.1%	9,185 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.28 - $14.85 $13,856 - $734,881	-49,487 Reduced 84.49%	9,085 $3,000
Q2 2022 Aug 10, 2022	BUY	$1.09 - $8.24 $63,843 - $482,633	58,572 New	58,572 $68,000

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.